Please be aware that this is a machine translation from French to English. AVICENN is not responsible for incorrect or inaccurate translations but welcomes suggestions for reformulation.

VeilleNanos - Towards the ban on titanium dioxide in cosmetics and medicines?

Towards the ban on titanium dioxide in cosmetics and medicines?

image
+ More info sheets
News
Agenda

After the ban in foodstuff, will we get a suspension of titanium dioxide in cosmetics (except sunscreens) and medicines?

By AVICENN – Last addition May 2024

Titanium dioxide (TiO2) is a white colorant in powder form, with a significant portion of its particles being of nanoscale size1smaller than 100 nanometers (1 nm = 0.001 µm = 1 billionth of a meter). It has been prohibited in foodstuffs in France in 2020, an in the entire European Union in 2022, following suspicions of colon carcinogenicity and of potential genotoxic risks. For now, titanium dioxide is still allowed at the non-nano scale for other oral cosmetic uses, such as toothpastes or lipsticks and balms (where it can be identified by the code CI 77891)2An opinion from the European Consumer Safety Committee (ECCS) is expected shortly..

Regarding medicinal products, the European Commission has laid the groundwork for a potential ban that could come into effect from 2025. Emphasizing that “it is crucial that the pharmaceutical industry makes every effort to accelerate research and development of alternative solutions to replace titanium dioxide (E171) in medicines”3See recitals 14 to 18 and article 3 of the European regulation 2022/634..

The ban of (nano)particles of titanium dioxide in consumer products has been requested for about ten years by various organizations (associations, journalists, health agencies, …). These demands have accelerated recently with the ban of titanium dioxide in foodstuffs (E171) in 2020.
AVICENN is compiling below the requests in favor of the extension of this ban to cosmetics likely to be ingested and/or inhaled (toothpastes, make-up, lip balms…) and to medicines.

Chronology:

In 2024

  • 2 May 2024: CHEM Trust calls for the next round of EU decision-makers to introduce policies that ensure we have toxic-free toothpastes and consumer products (e.g, withoug titanium titane, without endocrine disruptors, etc.)
  • 23 March 2024 : Le Moniteur des pharmacies n°3506 asks: “Titanium dioxide and medicines, all white or all black?” and relays the opinions of experts from INRAé, LEEM and C2DS, as well as the insights of Mathilde Detcheverry from AVICENN and her key proposal: that health authorities make available to the public a regularly updated list of medicines available without E171, so that patients are informed of titanium dioxide-free references when they exist.
  • 14 March 2024: The Danik consumer group Forbrugerrådet Tænk has identified 1️⃣1️⃣ toothpastes, out of the 3️⃣1️⃣ examined, that contain titanium dioxide (CI77891). It’s less than the year before.
  • 29 February 2024 : A study published in Frontiers in Pediatrics and carried out by researchers from Bordeaux shows that in utero exposure to E171 and its titanium dioxide nanoparticles can impair respiratory function in newborn mice.
  • January 2024 : The AVICENN nano-chronicle published in issue 528 of S!lence magazine asks the question: E171 in medicines: indispensable, really?
  • The January 17 issue of L’information dentaire publishes an article entitled “Les nanomatériaux au cabinet. Les repérer pour promouvoir la santé“, which ends with an insert dedicated to titanium dioxide nanoparticles in toothpastes and medicines: “TiO2: towards an acceleration of its removal thanks to awareness-raising work!”

In 2023

  • 5 & 8 December 2023 : On December 5, the European Committee for Consumer Safety (SCCS) publishes its preliminary scientific opinion on TiO2 in cosmetics, available for comment until February 6, 2024. Interviewed by ENDS Europe, Natacha Cingotti, from HEAL, commented asking for the implementation of the precautionary principle: “the European Commission should not allow it in cosmetics products as long as the important health concerns cannot be excluded”.
  • 23 November 24 2023: In an article entitled “Nanoparticles: why so many drugs still contain titanium dioxide“, the OBS recalls that E171 “is used to whiten tablets and stabilize formulas. “It protects tablets from ultraviolet radiation and thermal conditions which could disrupt the stability of a product”, explains Thomas Borel of Leem (the French federation of medicine companies). An argument often dismissed by the scientific community which considers that medicines enclosed in opaque boxes and often in blisters are, in general, well protected from solar radiation”, writes Christelle Pangrazzi, who adds: “what about its effects in patients suffering from chronic pathologies requiring several medications, daily, for months, even years?”
  • 23 November 2023: An article by researchers from INSERM, CEA, CNRS, CEA, etc. published in Particle and Fibre Toxicology shows that perinatal foodborne titanium dioxide exposure-mediated dysbiosis predisposes mice to develop colitis through life.
  • 22 August 2023 : 60 millions de consommateurs warns about the presence of titanium dioxide (CI 77891) in lipsticks : “All the lipsticks in our selection contain it”, although it is “suspected of promoting colorectal cancer”.
  • 20 July 2023 : In its article entitled “Towards a total ban on titanium dioxide?“, 60 millions de consommateurs magazine points out that the situation is moving more slowly on the drugs front than on the toothpaste front. Citing figures provided by AVICENN, the magazine points out that TiO2 has been withdrawn from almost 75 toothpaste references since 2019, not counting the very many new toothpastes that have since been formulated without TiO2 as soon as they were first placed on the market. On the drugs side, however, references are rarer for the time being. But the trend towards elimination should also accelerate: “Upsa has withdrawn TiO2 from Efferalgan film-coated tablets and Sanofi (…) from all Doliprane formulations, except capsules”.

In 2022

“Treated for heart problems, I take atenolol (Tenormin), amlodipine, and atorvastatin for cholesterol: these 3 drugs contain E171 as an excipient. Still for the heart, I take Kardegic 75 which causes weakness of the blood vessels, hence hemorrhoids which I treat with Daflon, also containing E171.

Unfortunately, I suffer from prostatitis, so I take either Permixon or Tadenan, 2 pills a day, also containing E171…

When I have trouble sleeping, I take Zopiclone, which contains the same excipient, and if I want to make it lighter by taking Euphytose, I find myself facing the same problem…(…)

In short, I find that the cumulative effect is not taken seriously either by the laboratories or by the Ministry of Health, while pastry chefs have excluded this product from their preparations. (…) There you go, just in case my voice could be heard somewhat, and you could help with that.”

  • December 14, 2022: Anses published its opinion on the risk assessment of the nanometric fraction of the food additive E171 which points out the lack of toxicological data available to perform a complete assessment of the additive E171 and recommends limiting the uses and exposures of workers and consumers to nanomaterials, “by promoting the use of safe products, free of manufactured nanomaterials, and by limiting these uses to those considered in fine as duly justified and subject to a documented demonstration of risk acceptability”.
  • June 21, 2022: The European Commission asked the Scientific Committee on Consumer Safety (SCCS) to re-evaluate the safety of TiO2 in cosmetics, with regard to its genotoxicity in case of inhalation and oral exposure. Among the types of cosmetics mentioned: lip balms, lipsticks, toothpastes, powders and hair sprays. The CSSC has nine months to issue its opinion, which should therefore be finalized in March 2023.
  • January 14, 2022: the European regulation 2022/63 banning the food additive titanium dioxide (E171) opens the possibility, in its article 3, of a ban on E171 in medicines – a decision that could be taken in 2025. By April 2024, the European Medicines Agency (EMA) will need to complete an updated assessment before the European Commission can reconsider the need to keep titanium dioxide (E171) on the list of colorants used in medicines, taking into account progress made in the meantime to develop alternatives. “If the replacement of titanium dioxide (E171) in medicinal products has not taken place or has not started within the above-mentioned time frame, only verifiable objective reasons related to the impossibility to replace it should be taken into consideration”

In 2021

  • December 24, 2021: relaying the investigation of Kali (see above), France 3 interviewed Pauline Cervan of Générations futures who denounces the fact that titanium dioxide has no role on the effectiveness of drugs, but presents risks of carcinogenicity and genotoxicity
  • December 22, 2021: Kali magazine made its “front page” on the 800 drugs containing titanium dioxide and calls for the withdrawal of TiO2 from drugs
  • October 28, 2021: Que Choisir denounced, with AVICENN, the fact that the European Medicines Agency (EMA) is the voice of laboratories and regretted that a deadline for substitution, provided by a regulatory text, had not been established by the European Commission
  • October 21, 2021: Karine Jacquemart of Foodwatch called for a ban on titanium dioxide in medicines and toothpaste.
  • October 2021: following the approval by the Member States of the ban on E171 in food throughout the European Union, we learned that medicines will not be affected for several years
  • May 6, 2021: the European Commissioner for Health and Food Safety, Stella Kyriakides, announced that the European Commission will propose a European ban on E171; this announcement was made just hours after the publication of the notice of the European Food Safety Agency (EFSA) concluding that this additive can no longer be considered “safe”, due to potential genotoxic effects (DNA damage). This is a clear shift in EFSA’s position, who until now had been adamant that E171 is safe – despite the numerous scientific publications that have been accumulating for several years and showing adverse effects. This reversal confirms the relevance of the alerts launched – for more than ten years now – by scientists and associations and taken seriously by the French authorities, who have suspended E171 since 2020.
  • March 4, 2021: the association Agir pour l’Environnement announces on Facebook that 7 new brands have committed to remove titanium dioxide from their toothpastes; their website https://dentifrice-infoconso.agirpourlenvironnement.org has recently been updated

In 2020

  • October 22, 2020: the association Agir pour l’Environnement launched a petition “Stop titanium” asking for the extension of the ban on titanium dioxide to medicines and toothpastes (more than 30 000 signatures collected):
  • 16 October 2020: Que Choisir also reiterated its call for a broadening of the ban on this additive to drugs and cosmetics likely to be ingested (toothpaste, lipstick …):
  • October 7, 2020: a study by French researchers showed that pregnant women’s exposure to titanium dioxide leads to an accumulation of TiO2 nanoparticles in the placenta and contamination of the fetus. It was conducted by scientists from INRAE, LNE, the Rouen Materials Physics Group, the Toulouse University Hospital, the University of Picardie Jules Verne and the Toulouse National Veterinary School. It confirmed strong presumptions, following publications of tests in animals. As the INRAE press release reminded us, the use of titanium dioxide in foodstuffs has been suspended in France, but it is still used in toothpastes, anti-UV screens, cosmetic creams and powders and pharmaceutical products. In a press release published the same day, Agir pour l’Environnement asked for the extension of the E171 ban to medicines and toothpastes.

In 2019

  • 19 November 2019 : NGOs Agir pour l’Environnement and AVICENN, interviewed on the Swiss consumer reference program “A bon entendeur” mention the impact of TiO2 ban in food on the toothpaste and pharmaceutical sectors (“domino effect”)
  • August 2019: the LR senator of the Alpes-Maritimes, Colette Giudicelli, submitted a written question (No. 11991) to the Minister of Solidarity and Health at the time, on the presence of nanoparticulate titanium dioxide in toothpastes and some drugs. At the end of September, AVICENN learned that the question, although forwarded to the Ministry of Economy, Finance and Recovery, has been “withdrawn due to the death of the senator”.
  • June 2019: the consumer association Que Choisir urged the European authorities to ban without delay the titanium dioxide present in nearly 7000 cosmetic references likely to be ingested (toothpastes, mouthwashes, lipsticks and lip balms, etc.).
  • June 2019: Interviewed by Challenges5Cf. Why titanium dioxide has been banned from plates, but not from toothpastes, Challenges, June 7, 2019, Anne Dux, director of scientific affairs at Febea, the professional association of the cosmetics sector, apparently answered that in toothpastes, there is no possible substitute for TiO2 as a white colorant because titanium dioxide is the only one not to interact with other elements. The obstacle to its removal according to her: “studies show that in the minds of consumers, white is associated with cleanliness and that this encourages them to brush their teeth more”. However, some brands have always done without it, others have already started to remove it from their toothpastes and some even make the absence of TiO2 in their toothpaste a marketing argument6In October 2018, the retailer Casino, pledged to remove TiO2 nanoparticles from “all of its products,” including toothpaste, by the end of the year. In January 2019, AVICENN also spotted the Dentavie brand toothpaste marketed by Laboratoire Léa Nature, which is guaranteed to be “free of unnecessary and controversial ingredients,” including no “titanium dioxide.”.
  • March 2019: the association Acting for the Environment (APE) asked the cabinet of the Minister of Economy and Finance, Bruno Le Maire, to extend the suspension of titanium dioxide to all products that can be totally or partially ingested: toothpastes and medications in particular, reporting the presence of titanium dioxide (TiO2) in two thirds of the 408 toothpastes. Not one was labeled [nano], mention mandatory on the packaging for any ingredient of nanometric dimension present in cosmetics. The day after the meeting, Agir pour l’Environnement indicated in a press release that “the meeting was very disappointing”, because there was no question, for the moment, of extending the scope of the decree to products other than food for various reasons. One of the reasons mentioned was that the draft order was designed for a food framework…but this framework could be changed in the drafting of the order. On the absence of [nano] labeling of titanium dioxide, the DGCCRF had not yet conducted investigations on toothpastes but indicated that it had planned to do so in the coming months. For Agir pour l’Environnement, this status quo showed “once again” the timidity of the Ministry of Economy, unable to protect consumers, children and patients, from exposure to a dangerous and unnecessary chemical substance in food, toothpaste and medicines. Without waiting for an investigation by the DGCCRF and the dissuasive sanctions that Agir pour l’Environnement was calling for, it put the toothpaste.infoconso. org website online. The site allows to quickly identify toothpastes with and without titanium dioxide. In the Agir pour l’Environnement investigation report published at the time, the association indicated that it had found TiO2 in two-thirds of the 408 toothpaste compositions it studied (including 25 organic toothpastes) and in half of the 60 children’s toothpastes. It also revealed that none of the 271 toothpastes concerned bore the mention [nano], which is mandatory on the packaging for any ingredient of nanometric dimension present in cosmetics. Agir pour l’environnement indicated that it had also launched a participatory survey on the presence of titanium dioxide in medicines.

In 2018

  • October 2018: “60 Millions de consommateurs” denounced the almost systematic use of TiO2 for applications where the anti-UV function is not strictly necessary is controversial, notably in anti-wrinkle creams: “The filters incorporated in these anti-wrinkle products are controversial. In particular (…) titanium dioxide in nano form. In a care cream with a purely aesthetic aim such as an anti-wrinkle cream, the presence of UV filters with a proven risk, or even only suspected of toxicity, is not acceptable”.7Cf. ” Anti-wrinkle creams: unwelcome UV filters,” 60 Millions de consommateurs, October 25, 2018.
  • June 2018: online petition “Stop carcinogenic titanium dioxide in our medicines!” (to the attention of the Minister of Health, on the platform citizaction.fr which is no longer online) > early November 2019 it had collected more than 20,000 signatures
  • February 2018: Que Choisir highlighted TiO2 in Aquafresh toothpaste with 40% of particles smaller than 100 nm.

In 2017

  • October 2017: BD nano waq published, co-financed by Agir pour l’Environnement, Générations futures, France Nature Environnement and the Committee for Sustainable Development in Health (C2DS)
  • June 2017: “Temporarily banning nanomaterials of questionable safety in food, drugs and toothpaste in France” is one of the eleven proposals compiled by AVICENN, in partnership with its associated members and other civil society actors as well as risk assessment and management bodies in the framework of the nanomaterials labeling/restriction working group led by the Ministry of the Environment

In 2009

Any questions or comments? This information sheet compiled by AVICENN is intended to be completed and updated. Please feel free to contribute.

Upcoming Nano Agenda

6
Juin
2024
Managing the risks associated with nanomaterials (CEA, Grenoble)
Grenoble
Training
  • Awareness-raising aimed at personnel in contact with nanomaterials during research, formulation, production, maintenance, cleaning, upkeep, etc., as well as safety coordinators or engineers, facility managers, heads of laboratories where nanoparticles are handled.
  • Organizers: INSTN Grenoble (CEA)
  • On the agenda: potential impact on health; metrology and protection; control of potential risks associated with nanomaterials; consideration of societal aspects.
  • Website: https://instn.cea.fr/formation/maitrise-des-risques-lies-aux-nanomateriaux-sensibilisation
6
Juin
2024
Nanomaterials and Health (ANSES, Maisons-Alfort)
Maisons-Alfort
Dialogue Committee
10
Juin
2024
Nanoparticles NPC-24 (ETH, Zurich)
Zurich
Conference
  • 27th ETH Nanoparticles Conference
  • Organizer: ETH Zurich
  • From June 10 to June 14, 2024
  • Website: https://npc24.scg.ch

File originally created in March 2019


Notes and references

Our monitoring, information and actions need you to continue !